Nanocurcumin supplementation ameliorates Behcet's disease by modulating regulatory T cells: A randomized, double-blind, placebo-controlled trial.
Int Immunopharmacol. 2021 Dec;101(Pt B):108237. doi: 10.1016/j.intimp.2021.108237. Epub 2021 Oct 12.PMID: 34653732 Clinical Trial.
Current research was designed to assess the effects of nanocurcumin supplementation on regulatory T (Treg) cells frequency and function in Behcet's disease (BD). In this randomized double-masked, placebo-controlled trial, 36 BD subjects were randomly put into …
Curcumin reduces the expression of interleukin 1beta and the production of interleukin 6 and tumor necrosis factor alpha by M1 macrophages from patients with Behcet's disease.
Immunopharmacol Immunotoxicol. 2018 Aug;40(4):297-302. doi: 10.1080/08923973.2018.1474921. Epub 2018 May 28.PMID: 29806793
